Bio-drugs are also referred as biomedicine, Western medicine, mainstream medicine, or conventional medicine. It is a branch of medical science that applies biological and physiological principles to clinical practice. Bio-drugs are based on standardized, evidence-based treatment validated through biological research, with the treatment administered through formally trained doctors, nurses, and other such licensed practitioners.
It includes many other biomedical disciplines and areas of specialty that contain the "bio" prefix such as molecular biology, biotechnology, biochemistry, embryology, cell biology, Nanobiotechnology, biological engineering, laboratory medical biology, genetics, cytogenetics, gene therapy, systems biology, bioinformatics, biostatistics, microbiology, anatomy, toxicology, neuroscience, parasitology, virology, immunology, pathology, physiology, and many that usually concern with life sciences as applied to medicine.
A biomolecule is also known as a biological molecule. It is a used term for molecules present in organisms that are essential to one or more typically biological processes, such as cell division, morphogenesis, or development. It also includes large macromolecules such as carbohydrates, proteins, lipids, and nucleic acids, as well as small molecules such as natural products primary metabolites, secondary metabolites.
The four major types of biomolecules are carbohydrates, lipids, nucleic acids, and proteins.
In other terms, Biotherapeutics are also called biologicals. Biotherapeutics are drug therapy products, where the active ingredient is extracted from a biological source. These products include recombinant proteins and hormones, growth factors, monoclonal antibodies cytokines, gene therapy products, gene-silencing/editing therapies, vaccines, cell-based products, tissue-engineered products, and stem cell therapies.
Important Alert:
X
Title : Personalized and precision medicine (PPM) as a unique healthcare model to be set up via biodesign, bio- and chemical engineering, translational applications, and upgraded business modeling to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Photodegradation of two pharmaceutical namely levofloxacin and atorvastatin via Chitosan/Ag/TiO2 3D printed scaffold
Delia Teresa Sponza, Dokuz Eylul University, Turkey
Title : Clinical pharmacology of aprocitentan (an endothelin receptor antagonist) – The most recent quality progress in treatment of resistant hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Preparation and characterization of fibers crafted from PCL/PVP-ChAgG, coupled with investigating their suitability as wound dressings.
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico
Title : Is your drug delivery formulation harming the environment ? Approaches to both save human health and the environment
Thomas J. Webster, Mansfield Bioincubator, United States
Title : Unveiling the binding interactions of selected antimalarial drugs with major plasma transporter
Saad Tayyab, UCSI University, Malaysia
Title : Pharmacokinetic properties of TNX-102 SL, a sublingual formulation of cyclobenzaprine hydrochloride
Bruce Daugherty, Tonix Pharmaceuticals, United States
Title : Drug design for the development of long-acting injectables
Thomas Ullrich, Novartis Biomedical Research, Switzerland
Title : Mannitol as eutectic forming agent for improved sublingual delivery of Cyclobenzaprine HCl
Marino Nebuloni, University of Insubria, Italy